These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10201131)

  • 1. [HTLV-I-associated myelopathy].
    Osame M
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):41-5. PubMed ID: 10201131
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HTLV-I-associated myelopathy].
    Osame M
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):389-92. PubMed ID: 1607802
    [No Abstract]   [Full Text] [Related]  

  • 4. HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
    Watanabe A; Kawajiri M; Ikezoe K; Osoegawa M; Murai H; Ochi H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jun; 221(1-2):95-7. PubMed ID: 15178221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical features of HTLV-I infection. HTLV-I associated myelopathy].
    Nakagawa M; Izumo S; Ikurou M; Osame M
    Uirusu; 1992 Jun; 42(1):21-8. PubMed ID: 1413532
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy for HAM/TSP and AIDS].
    Nakagawa M; Maruyama Y; Osame M
    Nihon Rinsho; 1994 Nov; 52(11):3019-25. PubMed ID: 7996704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HTLV-I--associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Makino M
    Ryoikibetsu Shokogun Shirizu; 2000; (31):9-12. PubMed ID: 11269197
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful 2-year therapy with systemic interferon-alpha for HTLV-I associated myelopathy.
    Gazzola P; Cocito L; De Maria A; Gabutti G; Mancardi GL
    J Neurol Sci; 1999 Jan; 162(2):205-7. PubMed ID: 10202989
    [No Abstract]   [Full Text] [Related]  

  • 10. [HTLV-I associated myelopathy].
    Ge T; Wang G; Zhao B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Jun; 25(3):182-4. PubMed ID: 1395949
    [No Abstract]   [Full Text] [Related]  

  • 11. Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha.
    Feng J; Misu T; Fujihara K; Misawa N; Koyanagi Y; Shiga Y; Takeda A; Sato S; Takase S; Kohnosu T; Saito H; Itoyama Y
    J Neuroimmunol; 2004 Jun; 151(1-2):189-94. PubMed ID: 15145617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
    Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
    J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine.
    Broniscer A; Ribeiro RC; Srinivas RV; Behm FG; Head DR; Raimondi SC; Mandrell B; Gill P
    Leukemia; 1996 Jul; 10(7):1244-8. PubMed ID: 8684010
    [No Abstract]   [Full Text] [Related]  

  • 14. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
    Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathology and therapy of HTLV-I-associated myelopathy].
    Kira J
    Fukuoka Igaku Zasshi; 1996 Jan; 87(1):1-7. PubMed ID: 8820981
    [No Abstract]   [Full Text] [Related]  

  • 16. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
    Shuh M; Beilke M
    Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [With interferon and zidovudine against therapy refractory T-cell leukemias].
    Sauer H
    Fortschr Med; 1995 Dec; 113(34):8. PubMed ID: 8575716
    [No Abstract]   [Full Text] [Related]  

  • 18. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Furukawa Y; Yamashita M; Usuku K; Izumo S; Nakagawa M; Osame M
    J Infect Dis; 2000 Nov; 182(5):1343-9. PubMed ID: 11010842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma.
    Pagano JS
    N Engl J Med; 1995 Nov; 333(19):1285-6. PubMed ID: 7566010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.